Efficacy and long-term patency of fenestrated amplatzer devices in children

Catheterization and Cardiovascular Interventions

Volumn 70, Issue 4, 2007, Pages 578-584

  Lammers, Astrid E ^a   Derrick, Graham ^a   Haworth, Sheila G ^b   Bonhoeffer, Philipp ^a   Yates, Robert ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atrial septal defect; Atrial septal occluder; Pulmonary hypertension

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; WARFARIN;

ADOLESCENT; ARTICLE; CATHETER; CATHETER OCCLUSION; CHILD; CLINICAL ARTICLE; DEMOGRAPHY; DEVICE; ECHOCARDIOGRAPHY; FEMALE; FENESTRATION; HEART ATRIUM SEPTUM DEFECT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; MALE; PULMONARY HYPERTENSION; THROMBOSIS; WORLD HEALTH ORGANIZATION;

EID: 35348930598     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21216     Document Type: Article

References (31)

1. King TD, Mills NL. Nonoperative closure of atrial septal defects. Surgery 1974;75:383-388.
2. Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999;118:674-678. (Discussion 678-680).
3. Pedra CA, Pihkala J, Lee KJ, Boutin C, Nykanen DG, McLaughlin PR, Harrison DA, Freedom RM, Benson L. Transcatheter closure of atrial septal defects using the Cardio-Seal implant. Heart 2000;84:320-326.
4. Hausdorf G, Schneider M, Hebe J, Morf G, Alexi V, Berdjis F, Weng YG, Hetzer R, Lange PE. [Combined surgical-interventional procedure in congenital heart defects with postoperative, left ventricular dysfunction]. Z Kardiol 1992;81:276-282.
5. Fischer G, Kramer HH, Stieh J, Harding P, Jung O. Transcatheter closure of secundum atrial septal defects with the new self-centering amplatzer septal occluder. Eur Heart J 1999;20:541-549.
6. Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A. Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart 1999;82:559-562.
7. Zahn EM, Wilson N, Cutright W, Latson LA. Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation 2001;104:711-716.
8. Tomai F, Gaspardone A, Papa M, Polisca P. Acute left ventricular failure after transcatheter closure of a secundum atrial septal defect in a patient with coronary artery disease: A critical reappraisal. Catheter Cardiovasc Interv 2002;55:97-99.
9. Ewert P, Berger F, Nagdyman N, Kretschmar O, Dittrich S, Abdul-Khaliq H, Lange P. Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv 2001;52:177-180.
10. Micheletti A, Hislop A, Lammers A, Bonhoeffer P, Derrick G, Rees P, Haworth SG. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart 2006;92:969-972.
11. Sandoval J, Gaspar J, Pulido T, Bautista E, Martinez-Guerra ML, Zeballos M, Palomar A, Gomez A. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 1998;32:297-304.
12. Kerstein D, Levy PS, Hsu DT, Hordof AJ, Gersony WM, Barst RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 1995;91:2028-2035.
13. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002;106:92-99.
14. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: Predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005;45:1691-1699.
15. van Albada ME, Schoemaker RG, Kemna MS, Cromme-Dijkhuis AH, van Veghel R, Berger RM. The role of increased pulmonary blood flow in pulmonary arterial hypertension. Eur Respir J 2005;26:487-493.
16. Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 1986;55:449-458.
17. Rich S, Dodin E, McLaughlin VV. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol 1997;80:369-371.
18. Barst RJ. Role of atrial septostomy in the treatment of pulmonary vascular disease. Thorax 2000;55:95-96.
19. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation 2002;105:54-60.
20. Cooney TP, Thurlbeck WM. Pulmonary hypoplasia in Down's syndrome. N Engl J Med 1982;307:1170-1173.
21. Haworth SG. Pulmonary vascular disease in secundum atrial septal defect in childhood. Am J Cardiol 1983;51:265-272.
22. Loughlin GM, Wynne JW, Victorica BE. Sleep apnea as a possible cause of pulmonary hypertension in Down syndrome. J Pediatr 1981;98:435-437.
23. Lammers A, Hager A, Eicken A, Lange R, Hauser M, Hess J. Need for closure of secundum atrial septal defect in infancy. J Thorac Cardiovasc Surg 2005;129:1353-1357.
24. Andrews R, Tulloh R, Magee A, Anderson D. Atrial septal defect with failure to thrive in infancy: Hidden pulmonary vascular disease? Pediatr Cardiol 2002;23:528-530.
25. Davies H, Oliver GC, Rappoport WJ, Gazetopoulos N. Abnormal left heart function after operation for atrial septal defect. Br Heart J 1970;32:747-753.
26. Beyer J. Atrial septal defect: Acute left heart failure after surgical closure. Ann Thorac Surg 1978;25:36-43.
27. Schubert S, Peters B, Abdul-Khaliq H, Nagdyman N, Lange PE, Ewert P. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv 2005;64:333-337.
28. Peters B, Ewert P, Schubert S, Abdul-Khaliq H, Schmitt B, Nagdyman N, Berger F. Self-fabricated fenestrated Amplatzer occluders for transcatheter closure of atrial septal defect in patients with left ventricular restriction: Midterm results. Clin Res Cardiol 2006;95:88-92.
29. Kong HH, Gu XX, Titus JLJL, Kim THT-H, Urness MM, Han YMY-M, Hessliein PP, Bass JJ, Chun MM, Hunter DWDW. Creation of an intra-atrial communication with a new Amplatzer shunt prosthesis: preliminary results in a swine model. Catheter Cardiovasc Interv 2002;56:267-271.
30. Stumper O, Gewillig M, Vettukattil J, Budts W, Chessa M, Chaudhari M, Wright JG. Modified technique of stent fenestration of the atrial septum. Heart 2003;89:1227-1230.
31. Cheatham JP. Now we are making a hole in a device meant to close a hole: Why? How? Is there a better answer? Catheter Cardiovasc Interv 2005;64:519-521.